Neurocognition with maraviroc compared with tenofovir in HIV.

about

HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment.Treating HIV Infection in the Central Nervous System.

P2860

Q30234305-6CAA255B-BBA4-4D1D-A57F-076E832AE090 Q39077816-0031A2A1-04E2-4C7B-A345-B85FADE1C031

P2860

Neurocognition with maraviroc compared with tenofovir in HIV.

Item

http://www.wikidata.org/entity/Q39402373

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Neurocognition with maraviroc compared with tenofovir in HIV.

@en

Neurocognition with maraviroc compared with tenofovir in HIV.

@nl

type

Item

label

Neurocognition with maraviroc compared with tenofovir in HIV.

@en

Neurocognition with maraviroc compared with tenofovir in HIV.

@nl

prefLabel

Neurocognition with maraviroc compared with tenofovir in HIV.

@en

Neurocognition with maraviroc compared with tenofovir in HIV.

@nl

P1476

Neurocognition with maraviroc compared with tenofovir in HIV.

@en

P2093

AIDS Clinical Trials Group (ACTG) 5303 team

http://www.w3.org/2001/XMLSchema#string

Anthony Lee

http://www.w3.org/2001/XMLSchema#string

Babafemi O Taiwo

http://www.w3.org/2001/XMLSchema#string

Baiba Berzins

http://www.w3.org/2001/XMLSchema#string

David Rusin

http://www.w3.org/2001/XMLSchema#string

Ellen S Chan

http://www.w3.org/2001/XMLSchema#string

Kevin R Robertson

http://www.w3.org/2001/XMLSchema#string

Sachiko Miyahara

http://www.w3.org/2001/XMLSchema#string

Todd T Brown

http://www.w3.org/2001/XMLSchema#string

P2860

Macrophage inflammatory protein-1

Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming.

Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia

In vitro downregulation of matrix metalloproteinase-9 in rat glial cells by CCR5 antagonist maraviroc: therapeutic implication for HIV brain infection.

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-a

Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic.

A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis.

Neuropathogenesis of HIV-associated neurocognitive disorders: roles for immune activation, HIV blipping and viral tropism

HIV-1 target cells in the CNS.

P304

2315-2321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0000000000001189

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joseph J Eron

P577

2016-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27333088

http://www.w3.org/2001/XMLSchema#string

P932

5014739

http://www.w3.org/2001/XMLSchema#string

Neurocognition with maraviroc compared with tenofovir in HIV.

about

P2860

P2860

Neurocognition with maraviroc compared with tenofovir in HIV.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932